|
Q1 FY2027
As of Jun 28, 2026
|
Q4 FY2026
As of Mar 29, 2026
|
Q3 FY2026
As of Dec 28, 2025
|
Q2 FY2026
As of Sep 28, 2025
|
Q1 FY2026
As of Jun 29, 2025
|
Q4 FY2025
As of Mar 30, 2025
|
Q3 FY2025
As of Dec 29, 2024
|
Q2 FY2025
As of Sep 29, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 24, 2023
|
Q2 FY2024
As of Sep 24, 2023
|
Q1 FY2024
As of Jun 25, 2023
|
Q4 FY2023
As of Mar 26, 2023
|
Q3 FY2023
As of Dec 25, 2022
|
Q2 FY2023
As of Sep 25, 2022
|
Q1 FY2023
As of Jun 26, 2022
|
Q4 FY2022
As of Mar 27, 2022
|
Q3 FY2022
As of Dec 26, 2021
|
Q2 FY2022
As of Sep 26, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents (Note E) | ||||||||||||||||||||
| Accounts and other receivables, net (Note G) | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets (Note H) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $12,420 and $12,225, respectively | ||||||||||||||||||||
| Operating lease right-of-use assets, net (Note Q) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible asset, net (Note I) | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Current portion of long-term debt (Note P) | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities (Note K) | ||||||||||||||||||||
| Current portion of operating lease liabilities (Note Q) | ||||||||||||||||||||
| Deferred franchise fees | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of unamortized debt issuance costs of $239 and $257, respectively (Note P) | ||||||||||||||||||||
| Long-term portion of operating lease liabilities (Note Q) | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Common stock, $.01 par value; 30,000,000 shares authorized; 9,387,176 and 9,383,920 shares issued; and 4,097,661 and 4,094,405 shares outstanding at June 28, 2026 and March 29, 2026, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Stockholders’ equity before treasury stock | ||||||||||||||||||||
| Treasury stock, at cost, 5,289,515 shares at June 28, 2026 and March 29, 2026 | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...
